Non Invasive Colon Cancer Screening Market 2027 By Test Type, End-User | The Insight Partners

Non Invasive Colon Cancer Screening Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Test Type (Fecal immunochemical test, Guaiac-based fecal occult blood test (gFOBT), Stool DNA test); End-User (Hospital, Ambulatory Surgical Centers, Specialty Clinic, Home care setting)

Report Code: TIPRE00016664 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Colon cancer is the most common types of reported cancer in the world. The prevalence of colon cancer is growing each year, and clinical adjustments are in line for detecting the cause before late-stage development. Colon cancer, if detected at an early stage, can be treated by removing the premalignant polyps. Non-invasive colon cancer screening is one of the media to detect cancer cells' presence.

MARKET DYNAMICS

The Non Invasive Colon Cancer Screening Market is expected to grow significantly in the coming years owing to rising in new cases of colon cancer with the rise in government initiatives made leading to increase in R&D activities. In addition, the market player initiatives is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Non Invasive Colon Cancer Screening Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Non Invasive Colon Cancer Screening market with detailed market segmentation by test type , end-user, and geography. The Non Invasive Colon Cancer Screening market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Non-Invasive Colon Cancer Screening market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Non Invasive Colon Cancer Screening market is segmented on the basis of by test type , end-user. Based on test type, the market is segmented into Fecal immunochemical test, Guaiac-based fecal occult blood test (gFOBT), Stool DNA test. On the basis of end-user, the market is categorized as Hospital, Ambulatory Surgical Centers, Specialty Clinic, Home care setting.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Non Invasive Colon Cancer Screening market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Non Invasive Colon Cancer Screening market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Non Invasive Colon Cancer Screening market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Non Invasive Colon Cancer Screening market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Non Invasive Colon Cancer Screening market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Non Invasive Colon Cancer Screening market are anticipated to have lucrative growth opportunities in the future with the rising demand for Non Invasive Colon Cancer Screening in the global market. Below mentioned is the list of few companies engaged in the Non Invasive Colon Cancer Screening market.

The report also includes the profiles of key players in Non-Invasive Colon Cancer Screening market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Abbott Laboratories
  •   Beckman Coulter, Inc.
  •   Epigenomics AG
  •   Sysmex Corporation
  •   Quest Diagnostics
  •   Exact Sciences Corporation
  •   Novigenix SA
  •   CML Healthcare, Inc
  •   bioMérieux
  •   Cancertame

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Non Invasive Colon Cancer Screening Market - By Test Type
1.3.2 Non Invasive Colon Cancer Screening Market - By End-User
1.3.3 Non Invasive Colon Cancer Screening Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NON INVASIVE COLON CANCER SCREENING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NON INVASIVE COLON CANCER SCREENING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NON INVASIVE COLON CANCER SCREENING MARKET - GLOBAL MARKET ANALYSIS
6.1. NON INVASIVE COLON CANCER SCREENING - GLOBAL MARKET OVERVIEW
6.2. NON INVASIVE COLON CANCER SCREENING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NON INVASIVE COLON CANCER SCREENING MARKET - REVENUE AND FORECASTS TO 2027 - TEST TYPE
7.1. OVERVIEW
7.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
7.3. FECAL IMMUNOCHEMICAL TEST
7.3.1. Overview
7.3.2. Fecal immunochemical test Market Forecast and Analysis
7.4. GUAIAC-BASED FECAL OCCULT BLOOD TEST (GFOBT)
7.4.1. Overview
7.4.2. Guaiac-based fecal occult blood test (gFOBT) Market Forecast and Analysis
7.5. STOOL DNA TEST
7.5.1. Overview
7.5.2. Stool DNA test Market Forecast and Analysis
8. NON INVASIVE COLON CANCER SCREENING MARKET - REVENUE AND FORECASTS TO 2027 - END-USER
8.1. OVERVIEW
8.2. END-USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. AMBULATORY SURGICAL CENTERS
8.4.1. Overview
8.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
8.5. SPECIALTY CLINIC
8.5.1. Overview
8.5.2. Specialty Clinic Market Forecast and Analysis
8.6. HOME CARE SETTING
8.6.1. Overview
8.6.2. Home care setting Market Forecast and Analysis
9. NON INVASIVE COLON CANCER SCREENING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Non Invasive Colon Cancer Screening Market Overview
9.1.2 North America Non Invasive Colon Cancer Screening Market Forecasts and Analysis
9.1.3 North America Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By Test Type
9.1.4 North America Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By End-User
9.1.5 North America Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By Countries
9.1.5.1 United States Non Invasive Colon Cancer Screening Market
9.1.5.1.1 United States Non Invasive Colon Cancer Screening Market by Test Type
9.1.5.1.2 United States Non Invasive Colon Cancer Screening Market by End-User
9.1.5.2 Canada Non Invasive Colon Cancer Screening Market
9.1.5.2.1 Canada Non Invasive Colon Cancer Screening Market by Test Type
9.1.5.2.2 Canada Non Invasive Colon Cancer Screening Market by End-User
9.1.5.3 Mexico Non Invasive Colon Cancer Screening Market
9.1.5.3.1 Mexico Non Invasive Colon Cancer Screening Market by Test Type
9.1.5.3.2 Mexico Non Invasive Colon Cancer Screening Market by End-User
9.2. EUROPE
9.2.1 Europe Non Invasive Colon Cancer Screening Market Overview
9.2.2 Europe Non Invasive Colon Cancer Screening Market Forecasts and Analysis
9.2.3 Europe Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By Test Type
9.2.4 Europe Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By End-User
9.2.5 Europe Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Non Invasive Colon Cancer Screening Market
9.2.5.1.1 Germany Non Invasive Colon Cancer Screening Market by Test Type
9.2.5.1.2 Germany Non Invasive Colon Cancer Screening Market by End-User
9.2.5.2 France Non Invasive Colon Cancer Screening Market
9.2.5.2.1 France Non Invasive Colon Cancer Screening Market by Test Type
9.2.5.2.2 France Non Invasive Colon Cancer Screening Market by End-User
9.2.5.3 Italy Non Invasive Colon Cancer Screening Market
9.2.5.3.1 Italy Non Invasive Colon Cancer Screening Market by Test Type
9.2.5.3.2 Italy Non Invasive Colon Cancer Screening Market by End-User
9.2.5.4 Spain Non Invasive Colon Cancer Screening Market
9.2.5.4.1 Spain Non Invasive Colon Cancer Screening Market by Test Type
9.2.5.4.2 Spain Non Invasive Colon Cancer Screening Market by End-User
9.2.5.5 United Kingdom Non Invasive Colon Cancer Screening Market
9.2.5.5.1 United Kingdom Non Invasive Colon Cancer Screening Market by Test Type
9.2.5.5.2 United Kingdom Non Invasive Colon Cancer Screening Market by End-User
9.2.5.6 Rest of Europe Non Invasive Colon Cancer Screening Market
9.2.5.6.1 Rest of Europe Non Invasive Colon Cancer Screening Market by Test Type
9.2.5.6.2 Rest of Europe Non Invasive Colon Cancer Screening Market by End-User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Non Invasive Colon Cancer Screening Market Overview
9.3.2 Asia-Pacific Non Invasive Colon Cancer Screening Market Forecasts and Analysis
9.3.3 Asia-Pacific Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By Test Type
9.3.4 Asia-Pacific Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By End-User
9.3.5 Asia-Pacific Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Non Invasive Colon Cancer Screening Market
9.3.5.1.1 Australia Non Invasive Colon Cancer Screening Market by Test Type
9.3.5.1.2 Australia Non Invasive Colon Cancer Screening Market by End-User
9.3.5.2 China Non Invasive Colon Cancer Screening Market
9.3.5.2.1 China Non Invasive Colon Cancer Screening Market by Test Type
9.3.5.2.2 China Non Invasive Colon Cancer Screening Market by End-User
9.3.5.3 India Non Invasive Colon Cancer Screening Market
9.3.5.3.1 India Non Invasive Colon Cancer Screening Market by Test Type
9.3.5.3.2 India Non Invasive Colon Cancer Screening Market by End-User
9.3.5.4 Japan Non Invasive Colon Cancer Screening Market
9.3.5.4.1 Japan Non Invasive Colon Cancer Screening Market by Test Type
9.3.5.4.2 Japan Non Invasive Colon Cancer Screening Market by End-User
9.3.5.5 South Korea Non Invasive Colon Cancer Screening Market
9.3.5.5.1 South Korea Non Invasive Colon Cancer Screening Market by Test Type
9.3.5.5.2 South Korea Non Invasive Colon Cancer Screening Market by End-User
9.3.5.6 Rest of Asia-Pacific Non Invasive Colon Cancer Screening Market
9.3.5.6.1 Rest of Asia-Pacific Non Invasive Colon Cancer Screening Market by Test Type
9.3.5.6.2 Rest of Asia-Pacific Non Invasive Colon Cancer Screening Market by End-User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Non Invasive Colon Cancer Screening Market Overview
9.4.2 Middle East and Africa Non Invasive Colon Cancer Screening Market Forecasts and Analysis
9.4.3 Middle East and Africa Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By Test Type
9.4.4 Middle East and Africa Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By End-User
9.4.5 Middle East and Africa Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Non Invasive Colon Cancer Screening Market
9.4.5.1.1 South Africa Non Invasive Colon Cancer Screening Market by Test Type
9.4.5.1.2 South Africa Non Invasive Colon Cancer Screening Market by End-User
9.4.5.2 Saudi Arabia Non Invasive Colon Cancer Screening Market
9.4.5.2.1 Saudi Arabia Non Invasive Colon Cancer Screening Market by Test Type
9.4.5.2.2 Saudi Arabia Non Invasive Colon Cancer Screening Market by End-User
9.4.5.3 U.A.E Non Invasive Colon Cancer Screening Market
9.4.5.3.1 U.A.E Non Invasive Colon Cancer Screening Market by Test Type
9.4.5.3.2 U.A.E Non Invasive Colon Cancer Screening Market by End-User
9.4.5.4 Rest of Middle East and Africa Non Invasive Colon Cancer Screening Market
9.4.5.4.1 Rest of Middle East and Africa Non Invasive Colon Cancer Screening Market by Test Type
9.4.5.4.2 Rest of Middle East and Africa Non Invasive Colon Cancer Screening Market by End-User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Non Invasive Colon Cancer Screening Market Overview
9.5.2 South and Central America Non Invasive Colon Cancer Screening Market Forecasts and Analysis
9.5.3 South and Central America Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By Test Type
9.5.4 South and Central America Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By End-User
9.5.5 South and Central America Non Invasive Colon Cancer Screening Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Non Invasive Colon Cancer Screening Market
9.5.5.1.1 Brazil Non Invasive Colon Cancer Screening Market by Test Type
9.5.5.1.2 Brazil Non Invasive Colon Cancer Screening Market by End-User
9.5.5.2 Argentina Non Invasive Colon Cancer Screening Market
9.5.5.2.1 Argentina Non Invasive Colon Cancer Screening Market by Test Type
9.5.5.2.2 Argentina Non Invasive Colon Cancer Screening Market by End-User
9.5.5.3 Rest of South and Central America Non Invasive Colon Cancer Screening Market
9.5.5.3.1 Rest of South and Central America Non Invasive Colon Cancer Screening Market by Test Type
9.5.5.3.2 Rest of South and Central America Non Invasive Colon Cancer Screening Market by End-User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NON INVASIVE COLON CANCER SCREENING MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NON INVASIVE COLON CANCER SCREENING MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BECKMAN COULTER, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. EPIGENOMICS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SYSMEX CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. QUEST DIAGNOSTICS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. EXACT SCIENCES CORPORATION
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVIGENIX SA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. CML HEALTHCARE, INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BIOMéRIEUX
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CANCERTAME
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Beckman Coulter, Inc.
3. Epigenomics AG
4. Sysmex Corporation
5. Quest Diagnostics
6. Exact Sciences Corporation
7. Novigenix SA
8. CML Healthcare, Inc
9. bioMérieux
10. Cancertame
TIPRE00016664
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking